(Press-News.org) Cancer cells' appetite for sugar may have serious consequences for immune cell function, researchers at Washington University School of Medicine in St. Louis have learned.
The scientists found that when they kept sugar away from critical immune cells called T cells, the cells no longer produced interferon gamma, an inflammatory compound important for fighting tumors and some kinds of infection.
"T cells can get into tumors, but unfortunately they are often ineffective at killing the cancer cells," said Erika Pearce, PhD, assistant professor of pathology and immunology. "Lack of the ability to make interferon gamma could be one reason why they fail to kill tumors. By understanding more about how sugar metabolism affects interferon production, we may be able to develop treatments that fight tumors by enhancing T cell function. "
According to Pearce, inhibiting interferon gamma production also may help scientists treat autoimmune disorders in which T cells cause too much inflammation.
The results appear June 6 in Cell.
Pearce's insights arose from her research into the metabolism of T cells.
Like most cells, T cells can make energy either by using an efficient process called oxidative phosphorylation or a less efficient pathway called aerobic glycolysis.
Cells normally make most of their energy via oxidative phosphorylation, but they need oxygen to do so. If oxygen runs short, most cells switch to aerobic glycolysis. Low sugar levels can force cells to use oxidative phosphorylation for their energy.
Scientists aren't sure why, but many cells, including T cells, switch to aerobic glycolysis when they need to reproduce rapidly. T cells proliferate quickly as they begin to respond to invaders or tumors, and scientists have assumed their switch to aerobic glycolysis was essential for this replicative process.
For the new study, Chih-Hao Chang, PhD, a postdoctoral researcher in the Pearce lab and first author of the study, set up a system that allowed him to control the resources available to T cells in test tubes. Switching the sugars available to the cells let him force the cells to use either oxidative phosphorylation or aerobic glycolysis.
"The conventional view was that proliferating T cells needed to use glycolysis, " Chang said. "We found that wasn't true: they could also use oxidative phosphorylation to support proliferation."
After proliferation starts, the T cells can sustain themselves with either energy-making process. But a problem arose when the scientists forced the T cells to switch from aerobic glycolysis to oxidative phosphorylation.
"The proteins involved in glycolysis don't just disappear when glycolysis is turned off — they're pretty stable proteins, so they can hang around in the cell and participate in other processes," Pearce said. "In T cells this can be a problem since one of these proteins, GAPDH, can inhibit the production of interferon gamma."
When the scientists put T cells in a dish with cancer cells, which regularly consume large amounts of sugar, the T cells' ability to make inflammatory compounds was impaired. But when the researchers gave sugar directly to the T cells, production of those inflammatory compounds doubled.
"It's like an on-off switch, and all we need to do to flip it is change the availability of sugar," Pearce said. "T cells often can go everywhere — tumors, inflammation, infections — but sometimes they don't do anything. If we can confirm that this same switch is involved in these failures in the body, we might be able to find a way to put the fight back into those T cells."
###
Funding from the National Institutes of Health (AI091965 and CA158823 to ELP and CA164062 to EJP), the Canadian Institute of Health Research (MOP-93799 to RGJ), the Arthritis Society of Canada (RGJ), the Dutch Organization for Scientific Research (GJWvdW), and the Emerald Foundation Young Investigator Award (ELP) supported this research.
Chang C-H, Curtis JD, Maggi Jr. LB, Faubert B, Villarino Av, O'Sullivan D, Huang S C-C, van der Windt GJW, Blagih J, Qiu J, Weber JD, Pearce EJ, Jones G, and Pearce EL.Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell, online June 6, 2013. DOI 10.1016/
Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.
Tumors disable immune cells by using up sugar
2013-06-06
ELSE PRESS RELEASES FROM THIS DATE:
Living fossils? Actually, sturgeon are evolutionary speedsters
2013-06-06
ANN ARBOR—Efforts to restore sturgeon in the Great Lakes region have received a lot of attention in recent years, and many of the news stories note that the prehistoric-looking fish are "living fossils" virtually unchanged for millions of years.
But a new study by University of Michigan researchers and their colleagues reveals that in at least one measure of evolutionary change—changes in body size over time—sturgeon have been one of the fastest-evolving fish on the planet.
"Sturgeon are thought of as a living fossil group that has undergone relatively slow rates of ...
More cancer specialist nurses to improve hospital care
2013-06-06
Patients battling cancer have a better experience of care at hospitals that employ more cancer specialist nurses.
Research from the University of Southampton, shows that patients of better staffed hospitals are more likely to report being given more emotional support by nurses who work well together on wards.
Study author Peter Griffiths, Professor of Health Services Research at the University of Southampton, comments: "Cancer and its treatment can place a huge burden, both physical and psychological, on patients. Supporting people with cancer on the journey from diagnosis ...
A CNIO study tracks the evolutionary history of a cancer-related gene
2013-06-06
How and when evolution generates diversity or gives form to proteins, living beings' functional building blocks, are essential questions that still surround the theory of evolution. In humans, the majority of genes have emerged via genetic duplication, a strategy in which a gene generates two identical copies that can evolve to generate different proteins.
A study published today by scientists from the Spanish National Cancer Research Centre (CNIO) describes how a genetic duplication that took place in the vertebrate ancestor some 500 million years ago encouraged the ...
Basic science points to clinical application in stopping tumor survival in low-oxygen environments
2013-06-06
As tumors grow, their centers are squeezed of oxygen. And so tumors must flip specific genetic switches to survive in these hypoxic environments. A series of studies funded to do only basic science and published today in the journal Cell reports the serendipitous discovery of a druggable target necessary for the survival of tumors in these low-oxygen environments.
"This is a clear example of starting with a basic biology question that now turns out to be relevant to patients," says Joaquin Espinosa, PhD, investigator at the University of Colorado Cancer Center, associate ...
'Caldas tear' resolves puzzling seismic activity beneath Colombia
2013-06-06
SAN FRANCISCO, June 6, 2013 -- Colombia sits atop a complex geological area where three tectonic plates are interacting, producing seismicity patterns that have puzzled seismologists for years. Now seismologists have identified the "Caldas tear," which is a break in a slab that separates two subducting plates and accounts for curious features, including a "nest" of seismic activity beneath east-central Colombia and high grade mineral deposits on the surface.
In a paper published in the June issue of the Bulletin of the Seismological Society of America (BSSA), researchers ...
New DNA test on roo poo identifies species
2013-06-06
University of Adelaide researchers have developed a simple and cost-effective DNA test to identify kangaroo species from their droppings which will boost the ability to manage and conserve kangaroo populations.
The researchers developed the test using hundreds of collected droppings across north-eastern Australia and extracting DNA from the samples, published in the conservation journal Wildlife Research.
A unique pattern of DNA fragmentation was established for each species, eliminating the need for gene sequencing which is costly, much more time-consuming and requires ...
Added benefit of ingenol mebutate is not proven
2013-06-06
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did ...
Molecular VELCRO for chromosome stability
2013-06-06
The genome is full of sequence repetitions. Sequence motif is added after sequence motif, sometimes more than a hundred times. Erratically it seems. And these sequence motifs bind proteins that control transcription factors in regions of the genome where no transcription should occur. A conundrum.
Nicolas Thomä, group leader at the Friedrich Miescher Institute for Biomedical Research, and his team together with the team of David Shore at the University of Geneva, have now been able to give an answer and assign a function to this seeming inconsistency. In a study published ...
Added benefit of dapagliflozin is not proven
2013-06-06
Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the current standard therapy. No such added benefit can be derived from the dossier, however, because the drug manufacturer did not present any relevant data for any of the possible therapeutic indications ...
Big game hunting in Spain has increased in the last 30 years
2013-06-06
Since ancient times, the pressures of excessive hunting have contributed to the gradual decline of wildlife populations and even the extinction of certain species in many areas.
Researchers from the Polytechnic University of Madrid (UPM) and the Centre for Forestry Research (INIA-CIFOR) have studied the developments in big game in Spain between 1972 and 2007 to gain an understanding of the hunting trends of the last decades.
"We have analysed the general trends in official statistics on hunters, hunting weapons, hunting grounds and captures. Our main conclusion is that ...